This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bittl, J. A. Articles by Califf, R. M. Search for Related Content PubMed PubMed Citation Articles by Bittl, J. A. Articles by Califf, R. M.

Meta-Analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty

John A. Bittl, MD, FACC^*,*, Derek P. Chew, MBBS, MPH, Eric J. Topol, MD, FACC, David F. Kong, MD, FACC and Robert M. Califf, MD, FACC

^* Ocala Heart Institute, Munroe Regional Medical Center, Ocala, Florida, USA
Flinders Medical Center, Adelaide, Australia
Cleveland Clinic Foundation, Cleveland, Ohio, USA
Duke Clinical Research Institute, Durham, North Carolina, USA

View larger version (42K): [in a new window]   Figure 1 Mortality by treatment assignment up to 30 days. Trial abbreviations are given in Table 1. *The ERBAC control groups are identical. CBA = coronary balloon atherotomy; CI = confidence interval; DCA = directional coronary atherectomy; LA = (excimer or holmium) laser angioplasty; OR = odds ratio; PTRA = percutaneous transluminal rotational atherectomy; PTCA = percutaneous transluminal coronary angioplasty.

View larger version (40K): [in a new window]   Figure 2 Myocardial infarctions up to 30 days. Trial abbreviations are given in Table 1. *The ERBAC control groups are identical. Abbreviations as in Figure 1.

View larger version (42K): [in a new window]   Figure 3 Major adverse cardiac events up to 30 days. Trial abbreviations are given in Table 1. *The ERBAC control groups are identical. Abbreviations as in Figure 1.

View larger version (41K): [in a new window]   Figure 4 Angiographic restenosis up to 90 to 360 days. Trial abbreviations are given in Table 1. *The ERBAC control groups are identical. Abbreviations as in Figure 1.

View larger version (43K): [in a new window]   Figure 5 Cumulative revascularization rates up to 360 days. Trial abbreviations are given in Table 1. *The ERBAC control groups are identical. Abbreviations as in Figure 1.

View larger version (42K): [in a new window]   Figure 6 Major adverse cardiac event rates up to 360 days. Trial abbreviations are given in Table 1. *The control groups for the ERBAC Trial are identical. Abbreviations as in Figure 1.